Cumulative update on pregnancy outcomes after fingolimod treatment in patients with multiple sclerosis

被引：0
|
作者：
Prach, L. M. [1 ]
Moore, A. [1 ]
Rezaallah, B. [1 ]
Mcbride, G. [1 ]
Khan, I. A. [2 ]
Guennec, M. [3 ]
Bhatt, A. [2 ]
Geissbuehler, Y. [1 ]
Leon, S. Lopez [4 ]
Vukusic, S. [5 ]
Butzkueven, H. [6 ]
Tilson, H. [7 ]
Macdonald, T. M. [8 ]
Hellwig, K. [9 ]
机构：
[1] Novartis Pharma AG, Basel, Switzerland
[2] Novartis Healthcare Pvt Ltd, Hyderabad, Telangana, India
[3] IQVIA, Paris, France
[4] Novartis Pharmaceut, E Hanover, NJ USA
[5] Hosp Civils Lyon, Hop Neurol, Serv Neurol, Sclerose Plaques Pathol Myeline & Neuroinflammat, Lyon, France
[6] Monash Univ, MS & Neuroimmunol Unit, Cent Clin Sch, Alfred Ctr, Clayton, Vic, Australia
[7] UNC Gillings Sch Global Publ Hlth, Chapel Hill, NC USA
[8] Ninewells Hosp & Med Sch, Dundee, Scotland
[9] Ruhr Univ, St Josef Hosp, Dept Neurol, Bochum, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1118
引用
收藏
页码：646 / 646
页数：1
相关论文
共 50 条
  • [21] Initiating oral fingolimod treatment in patients with multiple sclerosis
    Singer, Barry A.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2013, 6 (04) : 269 - 275
  • [22] Rebound of multiple sclerosis activity during pregnancy after fingolimod withdrawal
    Rua, A.
    Sola Valls, N.
    Sepulveda, M.
    Blanco, Y.
    Llufriu, S.
    Saiz, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 819 - 819
  • [23] Disease reactivation after fingolimod cessation in Multiple Sclerosis patients with pregnancy desire: A retrospective study
    Callens, Alix
    Leblanc, Soline
    Le Page, Emmanuelle
    Edan, Gilles
    Jourdain, Aurore
    Coustans, Marc
    Wiertlewski, Sandrine
    Laplaud, David
    Videth, Dorothee
    Lallement, Francois
    Leray, Emmanuelle
    Michel, Laure
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 66
  • [24] Rebound Syndrome in Multiple Sclerosis Patients After Cessation of Fingolimod
    Hatcher, Stacy
    Waubant, Emmanuelle
    Nourbakhsh, Bardia
    Crabtree-Hartman, Elizabeth
    Graves, Jennifer
    NEUROLOGY, 2016, 86
  • [25] Rituximab versus Fingolimod after Natalizumab in Multiple Sclerosis Patients
    Alping, Peter
    Frisell, Thomas
    Novakova, Lenka
    Islam-Jakobsson, Protik
    Salzer, Jonatan
    Bjorck, Anna
    Axelsson, Markus
    Malmestrom, Clas
    Fink, Katharina
    Lycke, Jan
    Svenningsson, Anders
    Piehl, Fredrik
    ANNALS OF NEUROLOGY, 2016, 79 (06) : 950 - 958
  • [26] Rebound syndrome in multiple sclerosis patients after cessation of fingolimod
    Hatcher, Stacy E.
    Waubant, Emmanuelle
    Nourbakhsh, Bardia
    Crabtree-Hartmann, Elizabeth
    Graves, Jennifer S.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 25 - 25
  • [27] Multiple sclerosis reactivation after fingolimod discontinuation for planning pregnancy: a monocentric experience
    Jeantin, L.
    Bensa, C.
    Chauvin, M.
    Dade, M.
    Deschamps, R.
    Gueguen, A.
    Mossad, M.
    Diallo, S. S.
    Gout, O.
    De la Motte, M. Boudot
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 365 - 365
  • [28] Skin warts during fingolimod treatment in patients with multiple sclerosis
    Jaafar, N.
    Zeineddine, M.
    Massouh, J.
    Yamout, B.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 906 - 906
  • [29] Recurrence of disease activity during pregnancy after cessation of fingolimod in multiple sclerosis
    Meinl, Ingrid
    Havla, Joachim
    Hohlfeld, Reinhard
    Kuempfel, Tania
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (07) : 991 - 994
  • [30] Oral fingolimod for the treatment of patients with relapsing forms of multiple sclerosis
    Singer, B.
    Ross, A. P.
    Tobias, K.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (08) : 887 - 895
12345